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ethodology for Ventilation/Perfusion SPECT
arika Bajc, MD, PhD,* Brian Neilly, MD, FRCP,† Massimo Miniati, MD, PhD,‡
an Mortensen, MD, PhD,§ and Björn Jonson, MD, PhD*
Ventilation/perfusion single-photon emission computed tomography (V/Q SPECT) is the scin-
tigraphic technique of choice for the diagnosis of pulmonary embolism and many other
disorders that affect lung function. Data from recent ventilation studies show that the theoretic
advantages of Technegas over radiolabeled liquid aerosols are not restricted to the presence of
obstructive lung disease. Radiolabeled macroaggregated human albumin is the imaging agent
of choice for perfusion scintigraphy. An optimal combination of nuclide activities and acquisi-
tion times for ventilation and perfusion, collimators, and imaging matrix yields an adequate V/Q
SPECT study in approximately 20 minutes of imaging time. The recommended protocol based
on the patient remaining in an unchanged position during the initial ventilation study and the
perfusion study allows presentation of matching ventilation and perfusion slices in all projec-
tions as well as in rotating volume images based upon maximum intensity projections. Prob-
abilistic interpretation of V/Q SPECT should be replaced by a holistic interpretation strategy on
the basis of all relevant information about the patient and all ventilation/perfusion patterns. PE
is diagnosed when there is more than one subsegment showing a V/Q mismatch representing
an anatomic lung unit. Apart from pulmonary embolism, other pathologies should be identified
and reported, for example, obstructive disease, heart failure, and pneumonia. Pitfalls exist both
with respect to imaging technique and scan interpretation.




















ertain symptoms and signs are more commonly ob-
served in pulmonary embolism (PE) than in other con-
itions. However, a diagnosis of PE cannot be established by
linical features alone. The diagnosis of PE must be con-
rmed or refuted with the use of a conclusive imaging test.
ncreasing evidence indicates that the optimal test for the
etection of PE is ventilation/perfusion (V/Q) single-photon
mission computed tomography (SPECT) interpreted along
olistic principles. (Note: the ventilation/perfusion relation-
hip, which, for consistency with other articles in this issue of
he journal, is denoted “V/Q,” has also recently been referred
o in the European guidelines as “V/P.” Both forms are in
ommon use.) A methodology, including diagnostic algo-
ithms and interpretation rules, has recently been proposed
n the European guidelines for V/Q scintigraphy.1 An impor-
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oi:10.1053/j.semnuclmed.2010.07.002ant first step is the decision to undertake an imaging test.
he guidelines suggest the use of a clinical prediction model
or PE as suggested by Miniati et al2 or Wells.3 The model
ccording to Miniati et al has the advantage that it does not
epend on any laboratory test. An estimate of the likelihood
f PE can be made at the patient’s bedside with use of an
lectrocardiogram as the only additional test.
Resolution of PE in patients is variable. It has been re-
orted that most patients continue to have unresolved PE 6
onths after diagnosis.4 Others have reported rapid resolu-
ion of a large PE within days or even hours of the onset of
herapy.5-7 Therefore, and to reduce the risks associated with
ntreated disease, it is recommended that imaging tests for
E diagnosis should be carried out as soon as possible, pref-
rably within 24 hours of the onset of symptoms.8
In clinical practice, a test that is both fast and conclusive is
ssential. As the scintigraphic diagnosis of PE is determined
y regions with absent perfusion but preserved ventilation,
e, mismatch, an efficient protocol should comprise V/Q
tudies in one session.
asic Principles of PE Diagnosis
ach bronchopulmonary segment and subsegment is sup-



























































































416 M. Bajc et alone with apex towards the hilum and base along the pleural
urface. Emboli, which are usually multiple, occlude the ar-
eries causing lobar, segmental or subsegmental perfusion
efects within still ventilated regions (Fig.1). During the pro-
ess of resolution/breakdown of emboli, perfusion may be
nly partially restored, in which case the V/Q mismatch be-
omes less distinct. PE is often a recurring process that gives
ise to multiple emboli in various stages of resolution. The
bjective of this work is to outline a state-of-the-art method-




or scintigraphic ventilation studies the following agents
ave been used:
● inert gases 133Xe and 81mKr;
● radiolabeled aerosols [99mTc]-DTPA; and
● 99mTc-labeled Technegas.
ases
istorically, 133Xe was the agent that was used for ventilation
tudies.9,10 As it cannot be used for SPECT, it is not discussed
urther. 81mKr is a gas generated on-site from the parent ru-
idium (81Ru).11 It has the ideal gamma energy of 193 keV.
he short half-life of 13 seconds implies that inhaled 81mKr
isappears from the alveolar space by decay at a much faster
ate than by exhalation. At normal respiratory rates, the re-
ional alveolar 81mKr concentration will within minutes ap-
roach a level approximately proportional to regional venti-
ation.12 As 81mKr is a gas, central airway deposition does not
ccur. To illustrate regional alveolar ventilation, SPECT ac-
uisition is performed during continuous inhalation of 81mKr.
ecause 81mKr has greater gamma energy than 99mTc (140 keV),
/Q can be imaged simultaneously.13-15 Radiation exposure from a
1mKr study is particularly low. The effective dose for 6000 MBq
reference amount) is only approximately 0.2 mSv. The 81mKr gen-
igure 1 Patient with PE. Sagittal slices, right lung; ventilation with
orresponding perfusion images. Multiple areas with absent perfu-vion (arrows) and preserved ventilation.ratorcanbeusedonly foronedaybecause 81Ruhasahalf-lifeof4.6
ours. Limited access and high costs are further reasons why 81mKr
s used sparingly. Gutte et al15 reported that V/Q SPECT with 81mKr
as uninterpretable in 8% of patients because of poor technical
uality.
erosols
entilation scintigraphy is usually based upon inhalation of a
adiolabeled aerosol. The aerosol particles may be liquid or solid
nd are suspended in air. The deposition of the particles de-
ends on the aerodynamic properties of the particles, mainly
heir size. Large particles (2 m) are deposited mainly by
mpaction in large airways, from mouth to trachea. Particles
2m reach small airways and even alveoli and are deposited
y sedimentation and diffusion. Very fine particles (1 m) are
ainly deposited in alveoli by diffusion. At first, the challenge
or radio-aerosols was to make nebulized particles as small as
ossible. The need to use as small particles as possible has been
emonstrated by Friedlander.16 Aerosol deposition also de-
ends upon flow pattern. Turbulent flow enhances particle dep-
sition by impaction. This happens at bronchial branching and
rregularities, for example, in patients with chronic obstructive
ulmonary disease (COPD). This leads to “hot spots” ie, focal
reas of intense radionuclide accumulation, in the central air-
ays in ventilation images. Furthermore, high flow rates and
orced breathing patterns contribute to this problem.
An important property of an aerosol is its mass median
erodynamic diameter (MMAD). The MMAD takes into ac-
ount that the radioactivity carried by each liquid particle is
roportional to its volume, which increases with the diame-
er raised to the power of 3. Fifty percent of the radioactivity
esides in particles smaller than the MMAD and 50% in larger
articles.17 The MMAD should preferably be smaller than 1.2
m.18-21 It is not easy to define the aerodynamic properties of
n aerosol. Hydrophilic particles may grow in size as the
esult of the humid environment of the airways. Particle ag-
regation is another problem. A basic recommendation is
hat the maximum droplet size inhaled by the patient should
ot exceed 2 m. Due to the complexity of the physics be-
ind aerosol deposition patterns, the performance of a neb-
lizer must be evaluated clinically.
ater-Soluble Agents. The principal water-soluble agent
sed for ventilation scintigraphy is diethylene-triaminepen-
aacetic acid labeled with technetium, [99mTc]-DTPA. Be-
ause it is a molecule of intermediate size (492 Da) and sol-
ble in water, [99mTc]-DTPA diffuses through the alveolocapillary
embrane to the blood. In a healthy nonsmoker, elimination
f [99mTc]-DTPA occurs with a clearance half time of approx-
mately 70 minutes. Increased clearance rate, leading to a
horter clearance half time, is observed where there is alveo-
ar inflammation of any cause, such as alveolitis of allergic or
oxic nature and even in smokers.17,22,23 Clearance of [99mTc]-
TPA can for diagnostic purposes be measured using planar
r tomographic scintigraphy.24,25
olid Particle Agent. In many countries, Technegas (Cyclo-










































































































Methodology for V/Q SPECT 417mall particle size, ie, about 0.005 to 0.2 m.26 99mTc-labeled
olid graphite particles are generated in a furnace at high
emperature.27,28 The particles are hydrophobic but tend to
row by aggregation and should therefore be administered
ithin 10 minutes after generation.
omparison of Ventilation Agents
ases have the advantage that they are distributed according
o regional ventilation without any local accumulation on
irway walls. Ventilation scintigraphy using 81mKr is regarded
y many as the gold standard for ventilation studies, al-
hough its regional concentration does not perfectly match
entilation in areas with extremely high or low alveolar ven-
ilation in relation to volume.12
Ventilation studies with Technegas and with 81mKr give
imilar information.29-33 This reflects the fact that Technegas
articles are so small that the aerosol closely follows the gas
ow down to the alveoli, where they are deposited by diffu-
ion.31,34 In comparison with liquid radio-aerosols, Techne-
as has significantly fewer problems of central airway depo-
ition and peripheral “hotspot” formation in patients with
bstructive lung disease. Recently, a group of patients rou-
inely admitted for V/Q SPECT and a group of patients with
nown COPD were studied head to head with [99mTc]-DTPA
nd Technegas.35 In both groups, overall unevenness of ra-
iotracer deposition and degree of central deposition were
ore pronounced with [99mTc]-DTPA than with Technegas,
articularly in the obstructive patients. In some cases, mis-
atched perfusion defects were only identified by the use of
echnegas. This finding was attributable to the fact that gen-
ral peripheral unevenness of [99mTc]-DTPA obscured mis-
atch, whereas a better peripheral penetration of Technegas
ighlighted the mismatch. Accordingly, PE might have been
verlooked in COPD patients when [99mTc]-DTPA was used.
n a few patients, [99mTc]-DTPA yielded images of very poor
uality. It was concluded that Technegas is the superior im-
ging agent, particularly in patients with obstructive lung
isease. A further advantage using Technegas is that a few
reaths on the part of the patient are sufficient to deliver an
dequate amount of activity to the lungs.
erfusion Agents
99mTc]-MAA
echnetium-labeled particles of macroaggregates of human
lbumin ([99mTc]-MAA) are almost universally used as the
erfusion agent for lung scintigraphy. After intravenous in-
ection, the particles of size 15 to 100 m are lodged in the
ulmonary capillaries and in the precapillary arterioles in
roportion to perfusion. At least 60,000 particles are re-
uired to adequately image regional perfusion.36 In clinical
ractice, approximately 400,000 particles are routinely in-
ected. As there are approximately 300 million precapillary
rterioles and many billions of pulmonary capillaries, a very
mall fraction of pulmonary vessels will be occluded. It is
ecommended that in patients with pulmonary hypertension
he numbers of administered particles should be reduced in
roportion to the severity of the condition. In infants and ihildren, the number of particles is adjusted according to
eight.37 For the most uniform distribution, the [99mTc]-
AA suspension should be administered by slow intrave-




dministration of ventilation and perfusion agents should be
erformed with the patient in the supine position to mini-
ize gravitational gradients. During inhalation of the venti-
ation agent, activity over the lungs should be monitored to
nsure adequacy of pulmonary deposition.
To achieve adequate imaging quality, with low radiation
xposure and in a short time, relationships between activi-
ies, acquisition times, collimators, and acquisition matrix
ize for SPECT imaging must be optimized. These issues were
ystematically analyzed by Palmer et al24 in the context of a
ual head gamma camera. Doses of 25 to 30 MBq for venti-
ation studies and 100-120 MBq for perfusion studies were
ound to be suitable. When a general purpose collimator was
sed, a 64  64 matrix was adequate. This allowed a total
cquisition time of only 20 minutes. If a high-resolution col-
imator is preferred, a matrix of 128  128 should be used,
equiring higher doses and/or longer acquisition time. Many
onsider that this suggestion is not advocated because it does
ot yield images of significantly higher quality, but this is an
ssue to be decided by each center.
Many centers are using much greater administered doses. We
onsider that the activities and acquisition protocol of Palmer et
l should be used24 because radiation exposure should be opti-
ized to the lowest level possible if images of satisfactory quality
an be produced. When these acquisition parameters are used,
he total number of projections should be 120, or 3° angular
ncrements (60 with each camera head on a dual head cam-
ra). For ventilation, each projection should be for 10 sec-
nds. For the perfusion study that follows immediately after the
entilation study, projections of 5 seconds should suffice.
uring the examination it is important that the patient remains
n the same supine position, carefully maintained between ven-
ilaton and perfusion acquisitions. If 81mKr is used as the venti-
ation agent, both perfusion SPECT and ventilation SPECT can
e obtained simultaneously within 13 minutes (ie, 30 projec-
ions per head of 20 s each over 180°) with low-energy general-
urpose collimators and acquired in a 128  128 matrix.15
/Q SPECT Reconstruction and Display
mage reconstruction with the use of an iterative algorithm is
ecommended, for example, using Ordered-Subset Expectation
aximization with 8 subsets and 2 iterations.24,38,39 Standard
oftware can be used for this and also for image presentation in
rontal, sagittal and transverse projections as well as for presen-
ation of rotating 3-dimensional images. A further option is to
alculate and display ventilation:perfusion quotient images,











































418 M. Bajc et alion imaging and with ventilation background being subtracted
rom the perfusion tomograms.24,38 Hot spot removal is often an
ssential feature, particularly if [99mTc]-DTPA is used. Ventila-
ion activity (counts) must normalized to perfusion activity, and
hen V:Qq images can be calculated. V:Qq images facilitate diag-
osis and quantification of PE extension, particularly in com-
lex cases.7,38
igure 2 Patient with PE. Sagittal slice of right lung; ventilation,
erfusion and V: Qq(uotient) image. Mismatches are nicely delineated
n V:Qq image that provides an improved visualization of PE exten-
ion (arrows).
Figure 3 Overview image of ventilation, perfusion and V:
carefully aligned to each other.isplay Options
n overview of ventilation and perfusion in coronal and
agittal slices is useful for quality control and fast orienta-
ion. For review of the study, it is important to present the
mages so that ventilation and perfusion are carefully
ligned to each other (Fig. 3). This is greatly facilitated by
he one session protocol with the patient unchanged in
osition. The option to triangulate between frontal (coro-
al), sagittal, and transverse slices is essential for identifi-
ation of matching and nonmatching V/Q changes. Proper
lignment is also a prerequisite for V:Qq quotient images.
hese facilitate the interpretation and quantification of PE
xtension. However, quotient images are not crucial for
igh quality V/Q SPECT.
Volume images determined by maximum intensity projec-
ions are usually available with standard software. Such rotating
mages give a good overview of ventilation and perfusion
hanges. The evaluation of the segmental or nonsegmental char-
cter of the changes is thereby facilitated.
rotocols
ne-Hour Assessment
/Q scintigraphy should be performed according to a single
ay protocol for the following reasons: PE is an acute disease
hat should be diagnosed and treated without delay. There-
ore, and to save time and resources, V/Q SPECT should be
erformed in one session. As shown, a complete study re-
uires only 20 minutes for acquisition and, with optimal
anagement, 1 hour from referral to report.25,38,40 Perfusion
ssessment is fundamental to PE diagnosis. Therefore, the
xamination starts with a ventilation scan with as low an
dministered activity as possible that results in adequate im-
ge quality, or simultaneously with 81mKr V/Q SPECT.






















































































Methodology for V/Q SPECT 419PECT Lung Scanning in Pregnancy
n the western world, venous thromboembolism is a leading
ause of maternal death during pregnancy or postpartum.41
regnant women represent a young and healthy population, in
hich the interpretation of lung perfusion scintigraphy is usu-
lly straightforward.42 Although the radiation dose from V/Q
PECT is low, it is important to further minimize radiation ex-
osure to the proliferating breast tissue. Therefore, many pro-
ose a perfusion-only SPECT being performed on day 1, using a
ose of [99mTc]-MAA reduced to 50 MBq. In most cases, (90%-
5%), the perfusion pattern is normal. Hence PE is reliably
xcluded. Where the perfusion pattern is abnormal, subcutane-
us low molecular weight heparin can be given so that a venti-
ation study can be performed on day 2 to confirm mismatch.
The radiation dose to the female breast is much higher
ith X-ray multidetector computed tomography (MDCT)
han with V/Q SPECT. Even when a dose-saving regime is
sed, Hurwitz et al43 have noted that the dose to the breast
rom MDCT is about 25 times greater than from V/Q SPECT.
oreover, the sensitivity of MDCT has recently been shown
o be very low, probably due to hemodynamic circumstances
uring pregnancy.44-46 For the aforementioned reasons, we
ecommend that perfusion-only scintigraphy be considered
uring pregnancy.47-49 Another situation in which perfusion-
nly SPECT is recommended is in emergencies with a strong
uspicion of massive PE. As risks associated with perfusion
PECT are negligible, time can be saved when perfusion
PECT is readily available.
eporting
linical Pretest Probability and D-Dimer
n accordance with Bayes’ theorem, the population undergo-
ng a test is of fundamental importance to its interpretation.
or individual patients, the clinical pretest probability should
e estimated.50-55 This can be done empirically. In recent
ears, structured prediction models for PE have been devel-
ped.2,3,56-60 The model of Wells et al is the most frequently
sed.3 It depends on the subjective judgment of the medical
fficer as to whether an alternative diagnosis is less likely than
E and cannot be standardized.
A more precise prediction model is that of Miniati et al.2 It
ests on 16 variables, including older age, risk factors, preexist-
ng cardiopulmonary diseases, relevant clinical symptoms and
igns, and the electrocardiogram. The area under the receiver
perating characteristic curve was 0.90 in the derivation sample
n  1100), and 0.88 in the validation sample (n  400). In
ontrast to other prediction models, this model includes vari-
bles that are negatively associated with PE. This gives the model
flexibility that may explain why it performs equally well both
n predicting and ruling out PE. Easy-to-use software is available
t http://www.ifc.cnr.it/pisamodel.
The measurement of D-dimer—a breakdown product of
ross-linked fibrin clot—is widely used in the investigative
ork up of patients with suspected venous thromboembo-
ism.61,62 However, the test features a low specificity (40%)
ecause D-dimer may be raised in many conditions other phan venous thromboembolism, such as acute myocardial
nfarction, stroke, inflammation, active cancer, and preg-
ancy. The specificity decreases with age and, in elderly pa-
ients, may reach only 10%.61 Because of the low predictive
alue, a positive quantitative D-dimer test does not modify
he pretest probability. A negative quantitative D-dimer test
ombined with a low clinical probability is associated with a
ow risk of thromboembolic disease.61,62 At moderate to high
retest clinical probability, D-dimer has no added value.
/Q Patterns
s discussed previously, the principal pattern for PE is absent
erfusion in areas with preserved ventilation, ie, V/Q mismatch.
ulmonary arterial circulation can be affected by many disorders
thers than PE. In most diseases both V and Q are affected,
eading to patterns referred to as V/Q match or when ventilation
s more affected than perfusion, reversed V/Q mismatch.
For V/Q SPECT, we have previously proposed a new ho-
istic principle for reporting that we believe is as important as
he imaging technique itself. The clinician can only benefit
rom reports which clearly express the presence or absence of
E. This goal was not reached with the previous probabilistic
eporting methods according to Prospective Investigation Of
ulmonary Embolism Diagnosis (PIOPED) or modified
IOPED.50,63 Large V/Q SPECT trials have shown that inter-
retation of all patterns representing ventilation together
ith perfusion achieves this result.15,39,40,64 Conclusive re-
orts can be given in 97% to 99% of patients. It has been
hown that more than 0.5 segment of V/Q mismatch is suf-
cient for the diagnosis of PE.65
The holistic interpretation of V/Q SPECT should be based
pon:
● clinical pretest probability and
● criteria for interpreting V/Q patterns indicative for PE
and other diseases.
riteria for Acute PE
ur recommended criteria for interpreting V/Q SPECT with
espect to acute PE are the following47,49:
No PE is reported if there is (are)
● normal perfusion pattern conforming to the anatomic
boundaries of the lungs;
● matched or reversed mismatch V/Q defects of any size,
shape or number in the absence of mismatch, and;
● mismatch that does not have a lobar, segmental or sub-
segmental pattern.
PE is reported if there is
● V/Q mismatch of at least 1 segment or 2 subsegments
that conforms to the pulmonary vascular anatomy.
Nondiagnostic for PE is reported if there are
● Multiple V/Q abnormalities not typical of specific diseases.
he fundamental point is that for patients with clinical sus-
































































420 M. Bajc et alal, or subsegmental V/Q mismatch. Crucially, with PE, the
allmark is a mismatch that has its base along the pleura and
onforms to known subsegmental and segmental vascular
natomy, a fundamental principle stressed in the PISAPED
tudy.51 Applying these principles of interpretation, recent
/Q SPECT studies amounting to more than 3000 cases re-
ort a negative predictive value of 97% to 99%, sensitivities
f 96% to 99%, and specificities of 91% to 98% for PE
iagnosis. Rates of nondiagnostic findings were 1% to
%.39,40,64,66 V/Q SPECT yields ventilation and perfusion im-
ges in exactly the same projections, facilitating recognition
f mismatch. This is of particular importance in the middle
obe and lingula where mismatch may be overlooked if the
ung is not accurately delineated by its ventilation images.67
An important step in the diagnostic procedure is to quantify
he extent of embolism. V/Q SPECT is particularly suitable for
his because of its greater sensitivity compared with alternative
lanar scintigraphy and MDCT.15,64,68 As suggested by Olsson
t al,7 the number of segments and subsegments showing for PE
ypical mismatch are counted and expressed as a percentage of
he total lung parenchyma. Furthermore, areas with ventilation
bnormalities were recognized and this allowed the degree of
otal lung malfunction to be estimated. This may have treatment
mplications as this study showed that patients with up to 40%
f the lungs affected by PE could be safely treated at home if
entilation abnormalities engaged not more that 20% of the
igure 4 Patient with pulmonary hypertension caused by chronic
E. Coronal slices; Multiple segmental and subsegmental perfusion
efects (arrows) in ventilated areas, well delineated on V:Qq images.
DCT was normal.ung. Since 2004, about 60% of patients with PE, numbering mbout 800, have been safely treated at home in the University
ospital of Lund.
hronic Pulmonary Embolism
hronic PE is a progressive disease that develops in about 1%
o 5% after an acute episode of PE, even in treated patients.69
t often has, however, an insidious onset. It leads to pulmo-
ary hypertension, right heart failure, and arrhythmia, which
re frequent causes of death.70,71 The value of V/Q scintigra-
hy in this situation is well established.72,73 This has recently
een confirmed in a head-to-head comparison between
DCT and planar scintigraphy with pulmonary angiography
s reference.74 Among patients with pulmonary hyperten-
ion, scintigraphy had a sensitivity of 96% to 97% and spec-
ficity of 90%, whereas MDCT had a sensitivity of 51%. The
onclusion was that V/Q scintigraphy “has a higher sensitiv-
ty than MDCT as well as very good specificity in detecting
hronic pulmonary thromboembolic disease as a potentially
urable cause of pulmonary hypertension.” Scintigraphic fea-
ures of chronic PE vary.
Figure 4 illustrates a case of multiple perfusion defects that
re similar to acute PE. MDCT was normal. In some patients
ismatch without clear segmental or subsegmental pattern is
bserved. Peripheral zones of the lung lack perfusion. The cen-
er of the lung is hyperperfused. The lung appears significantly
maller on perfusion images compared with ventilation and the
:Qq images show mismatch along the lung periphery (Fig. 5).
In recent guidelines for the diagnosis and treatment of pul-
onary hypertension it is stated that “ventilation/perfusion scan
emains the screening method of choice for chronic pulmonary
ypertension.”75 It was also noted that pulmonary veno-occlu-
ive disease is a rare but important differential diagnosis.
igure 5 Patient with pulmonary hypertension caused by chronic PE. Sag-
ttal slices; peripheral zones of the lung lack perfusion (arrows). The center
f the lung is hyperperfused. The lung appears significantly smaller on
erfusion images compared with ventilation. V:Qq images shows mis-






























































Methodology for V/Q SPECT 421ther Diagnostic Outcomes
or alternative diagnoses to PE, the total pattern of V/Q dis-
ribution is crucial.
hronic Obstructive Pulmonary Disease
common alternative or additional diagnosis is COPD.
he hallmark is a general unevenness of ventilation. Focal
eposition may be observed in central or peripheral air-
ays even when Technegas is used. A very important fact
s that COPD patients are at high risk of PE. The rate of PE
n patients hospitalized for acute exacerbations of COPD
ay be as high as 25%.76 PE accounts for up to 10% of
eaths in stable COPD patients.77 The degree of uneven-
ess of aerosol distribution correlated with lung function
ests.78 With V/Q SPECT, PE can be diagnosed even in the
resence of COPD.47,49,64 Significantly, because there are
o contraindications toV/QSPECT,evenverysickandbreathless
atients can be studied. Figure 6 shows coronal slices in a
atient with COPD and chronic PE. Ventilation is very un-
ven in the whole lung. In addition, multiple perfusion de-
ects are seen in ventilated areas. Mismatch is highlighted in
:Qq images.
neumonia
mong patients investigated with V/Q SPECT for suspected PE,
neumonia is common.64 A typical finding is a ventilation defect
n a region usually with better preserved perfusion, known as
igure 6 Patient with COPD and chronic PE. Coronal slices; ventilation is
ery uneven in the whole lung. In addition, multiple perfusion defects are
een in ventilated areas. Mismatch is highlighted in V:Qq images.everse mismatch (Fig. 7).79,80 V/Q SPECT allows diagnosis of rE and pneumonia when combined in a patient with COPD
Fig. 8). One of the typical patterns, which strongly support the
iagnosis of pneumonia, is the “stripe sign.” It refers to main-
ained perfusion along the pleural surface, peripheral to a central
atched defect. A good example is shown in Figure 9B.81,82
eft Heart Failure
eft heart failure is a further diagnosis that is frequently ob-
erved among patients suspected of having PE. The typical
attern is antigravitational redistribution of perfusion.83,84 In
onsecutive patients with suspected PE, V/Q SPECT showed
edistribution of perfusion towards ventral lung regions in
5% of the cases indicating left heart failure.85 The positive
redictive value for heart failure was at least 88%. As venti-
ation is usually less redistributed than perfusion, V/Q mis-
atch may be observed in dorsal regions. Figure 9A shows a
/Q mismatch with a nonsegmental pattern which should
ot be misinterpreted as PE. The follow-up scan 10 days later
Fig. 9B) showed normalization of gravitational distribution
f V/Q. However, the patient had developed a clearly delin-
ated pattern of pneumonia in the upper right lobe.
omments
dvocates for MDCT stress that this method has the advan-
age over V/Q SPECT in that it allows alternative diagnoses. It
s also true, however, that V/Q SPECT provides evidence about
lternative diagnoses. In a V/Q SPECT study comprising 1785
atients, an alternative diagnosis was reported in 39% of pa-
ients without PE, whereas among patients with PE an additional
athology was reported in 22%.64 In fact, a properly performed
/Q SPECT that is interpreted by all patterns of ventilation and
erfusion very frequently allows diagnoses of other pulmonary
igure 7 Patient with suspected pneumonia in the right lung, seen
n chest X-ray. Sagittal slices; Absent ventilation posterior in the











422 M. Bajc et alisease, with or without PE, and may provided a comprehensive
nderstanding of the patient’s symptoms. This added value of
/Q SPECT appears at least as high as for MDCT. Further stud-
es are needed to demonstrate the clinical impact of alternative
iagnoses obtained by both methods.
Figure 8 Patient with COPD, complicated with pneumo
ventilation with central deposition of Technegas (interru
with relative preservation of perfusion and the “stripe si
In the left lung there is absent perfusion anteriorly whe
of PE and is well demonstrated on the V:Qq images (do
Figure 9 (A) Patient with left heart failure in the initia
ventilation and more so of perfusion, causing nonsegm
patient, follow-up after 10 days of treatment for left hea
However, the patient had developed a clearly delineated
V/Q with “stripe sign.”itfalls for V/Q SPECT
s with any diagnostic test, it is vital that the medical staff
embers reporting the V/Q scan are aware of many sources
f error related to technical factors or interpretation.
d PE. Sagittal slices: in the right lung, there is uneven
rrows). In the left lung, ventilation is absent posteriorly
awn arrows), which is a typical finding for pneumonia.
ntilation is preserved (mismatch). This is characteristic
ows).
stage. Sagittal slices: antigravitational distribution of
:Q mismatch in dorsal regions (arrows). (B) The same
re. Normalization of gravitational distribution of V/Q.
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● Incorrect handling of the [99mTc]–MAA preparation may
cause aggregation of particles, creating hot spots in the
images. Reasons may be inadequate shaking of the vial
with the MAA suspension or preinjection withdrawing
of blood into the syringe.
● When DTPA aerosols are used, ventilation images in
obstructive airway disease may be confounded by cen-
tral and peripheral airway deposition. However, this is
much less of a problem when Technegas is used.35
● In rare instances, in emphysema patients Technegas can
become trapped in bullae and lead to mismatch.66 The
pattern is however, not of a segmental or subsegmental
character and should not be mistaken for PE.
● Patient movement between ventilation and perfusion
scanning will cause artifacts in the V/Qq quotient im-
ages. The particular nonsegmental character distin-
guishes this pattern from PE (Fig. 10).
nterpretation
everal diseases and conditions lead to mismatch. Proper
ecognition of mismatch patterns characteristic for different
iseases is essential to avoid pitfalls in interpretation.
● In nonacute PE that is partly resolved, mismatched perfu-
sion defects that have lost their clear segmental character
may be seen with or without signs of acute PE and lead to
false negative diagnosis and inadequate treatment;
● Mismatched defects are observed in, for example, lung can-
cer, mediastinal lymphadenopathy, postradiation pneu-
Figure 10 Coronal slices: the V:Qq image displays nonse
pattern is typical for nonalignment due to patient movem
are overlaid on ventilation and perfusion images for quality comonitis, vasculitis, and heart failure. In general, such
mismatches have a nonsegmental character. It is very im-
portant to take all patient information into account to min-
imize the risks of misdiagnosis of diseases other than PE;
● Some emboli do not lead to mismatch because, like a
saddle embolus, they do not cause vascular occlusion.86
Nevertheless, a normal perfusion scan excludes PE ac-
cording to wide experience. Accordingly, missed major
nonocclusive emboli do not lead to clinical conse-
quences like sudden death. The reason for this is prob-
ably that such emboli are accompanied by small occlud-
ing emboli, which are detected with V/Q SPECT, so that
PE is diagnosed and treated. Small emboli should not be
overlooked or disregarded;
● Unilateral whole lung mismatch without any mismatch
in the other lung is usually not due to PE.87,88 In such
cases, a CT is recommended to reveal much more likely
pathologies, such as tumor and other mediastinal pro-
cesses or extremely rarely congenital pulmonary vascu-
lar abnormalities or aortic aneurysm;
● When V/Q abnormalities not typical for any particular
disease are observed, the patient should be referred to
MDCT to avoid both under and overdiagnosis of PE.
onclusions
n our opinion, V/Q SPECT is the best method for the diagnosis
f PE because it has highest diagnostic accuracy, very few non-
iagnostic reports and no contraindications or complications.
al “mismatch” along the left border of both lungs. This


















































424 M. Bajc et alurthermore, radiation doses are very low. This is particularly
mportant for women in the reproductive period and during
regnancy.
To take full advantage of the V/Q SPECT potential, it is crucial
o apply an optimal protocol for a single session imaging of both
entilation and perfusion using low radionuclide activities. Fur-
hermore, full use should be made of all display options, which
re available with modern camera and computer systems. Most
mportant of all is the holistic interpretation, giving a clear report
ith respect to PE, its extent as well as other diagnoses based on
/Q patterns typical for various diseases.
The above-mentioned advantages of V/Q SPECT for study-
ng PE imply that it should be recognized as the only suitable
echnique both for follow up in patients with PE as well as for
esearch regarding its treatment and pathophysiology.
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